Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, Knapp M, Lawton C, Lindesay J, Livingston G, McCrae N, Moniz-Cook E, Murray J, Nurock S, Orrell M, O'Brien J, Poppe M, Thomas A, Walwyn R, Wilson K, Burns A. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet. 2011 Jul 30;378(9789):403-11. Epub 2011 Jul 19 PubMed.

Recommends

Please login to recommend the paper.

Comments

  1. This paper describes carefully the comorbidity of depression and AD dementia.

    View all comments by Dr. Stephanie McCallum

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. A Paradigm Shift for Treating Depression in Alzheimer’s?

Therapeutics

  1. Mirtazapine
AlzAntibodiesAlzBiomarkerAlzRiskBrain BanksGeneticsAlzGeneHEXMutationsProtocolsResearch ModelsTherapeutics